Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.

Authors:
Angela Y Y Tam Amy L Horwell Sarah L Trinder Korsa Khan Shiwen Xu Voon Ong Christopher P Denton Jill T Norman Alan M Holmes George Bou-Gharios David J Abraham

Int J Biochem Cell Biol 2021 Mar 1;134:105961. Epub 2021 Mar 1.

Centre for Rheumatology and Connective Tissue Disease, Department of Inflammation, Division of Medicine, University College London, London, NW3 2PF, UK.

Connective tissue growth factor (CTGF, CCN2) is a matricellular protein which plays key roles in normal mammalian development and in tissue homeostasis and repair. In pathological conditions, dysregulated CCN2 has been associated with cancer, cardiovascular disease, and tissue fibrosis. In this study, genetic manipulation of the CCN2 gene was employed to investigate the role of CCN2 expression in vitro and in experimentally-induced models of pulmonary fibrosis and pulmonary arterial hypertension (PAH). Knocking down CCN2 using siRNA reduced expression of pro-fibrotic markers (fibronectin p < 0.01, collagen type I p < 0.05, α-SMA p < 0.0001, TIMP-1 p < 0.05 and IL-6 p < 0.05) in TGF-β-treated lung fibroblasts derived from systemic sclerosis patients. In vivo studies were performed in mice using a conditional gene deletion strategy targeting CCN2 in a fibroblast-specific and time-dependent manner in two models of lung disease. CCN2 deletion significantly reduced pulmonary interstitial scarring and fibrosis following bleomycin-instillation, as assessed by fibrotic scores (wildtype bleomycin 3.733 ± 0.2667 vs CCN2 knockout (KO) bleomycin 4.917 ± 0.3436, p < 0.05) and micro-CT. In the well-established chronic hypoxia/Sugen model of pulmonary hypertension, CCN2 gene deletion resulted in a significant decrease in pulmonary vessel remodelling, less right ventricular hypertrophy and a reduction in the haemodynamic measurements characteristic of PAH (RVSP and RV/LV + S were significantly reduced (p < 0.05) in CCN2 KO compared to WT mice in hypoxic/SU5416 conditions). These results support a prominent role for CCN2 in pulmonary fibrosis and in vessel remodelling associated with PAH. Therefore, therapeutics aimed at blocking CCN2 function are likely to benefit several forms of severe lung disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biocel.2021.105961DOI Listing
March 2021

Publication Analysis

Top Keywords

ccn2
12
pulmonary fibrosis
12
arterial hypertension
8
fibrosis pulmonary
8
pulmonary arterial
8
ccn2 gene
8
gene deletion
8
lung disease
8
vessel remodelling
8
pulmonary
8
role ccn2
8
connective tissue
8
tissue growth
8
growth factor
8
005
5
fibrosis
5
systemic sclerosis
4
measurements characteristic
4
sclerosis patients
4
lung fibroblasts
4

Keyword Occurance

Similar Publications

CTGF regulates cell proliferation, migration, and glucose metabolism through activation of FAK signaling in triple-negative breast cancer.

Authors:
Hyungjoo Kim Seogho Son Yunhyo Ko Incheol Shin

Oncogene 2021 Mar 10. Epub 2021 Mar 10.

Department of Life Science, Hanyang University, Seoul, 04763, Republic of Korea.

Connective tissue growth factor (CTGF), also known as CCN2, is a member of the CCN protein family of secreted proteins with roles in diverse biological processes. CTGF regulates biological functions such as cell proliferation, migration, adhesion, wound healing, and angiogenesis. In this study, we demonstrate a mechanistic link between CTGF and enhanced aerobic glycolysis in triple-negative breast cancer (TNBC). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension.

Authors:
Angela Y Y Tam Amy L Horwell Sarah L Trinder Korsa Khan Shiwen Xu Voon Ong Christopher P Denton Jill T Norman Alan M Holmes George Bou-Gharios David J Abraham

Int J Biochem Cell Biol 2021 Mar 1;134:105961. Epub 2021 Mar 1.

Centre for Rheumatology and Connective Tissue Disease, Department of Inflammation, Division of Medicine, University College London, London, NW3 2PF, UK.

Connective tissue growth factor (CTGF, CCN2) is a matricellular protein which plays key roles in normal mammalian development and in tissue homeostasis and repair. In pathological conditions, dysregulated CCN2 has been associated with cancer, cardiovascular disease, and tissue fibrosis. In this study, genetic manipulation of the CCN2 gene was employed to investigate the role of CCN2 expression in vitro and in experimentally-induced models of pulmonary fibrosis and pulmonary arterial hypertension (PAH). Read More

View Article and Full-Text PDF
March 2021
Similar Publications

RFX1-mediated CCN3 induction that may support chondrocyte survival under starved conditions.

Authors:
Tomomi Mizukawa Takashi Nishida Sho Akashi Kazumi Kawata Sumire Kikuchi Harumi Kawaki Masaharu Takigawa Hiroshi Kamioka Satoshi Kubota

J Cell Physiol 2021 Mar 3. Epub 2021 Mar 3.

Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Cellular communication network factor (CCN) family members are multifunctional matricellular proteins that manipulate and integrate extracellular signals. In our previous studies investigating the role of CCN family members in cellular metabolism, we found three members that might be under the regulation of energy metabolism. In this study, we confirmed that CCN2 and CCN3 are the only members that are tightly regulated by glycolysis in human chondrocytic cells. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Age-related elevation of HGF is driven by the reduction of fibroblast size in a YAP/TAZ/CCN2 axis-dependent manner.

Authors:
Yaping Xiang Zhaoping Qin Yan Yang Gary J Fisher Taihao Quan

J Dermatol Sci 2021 Feb 16. Epub 2021 Feb 16.

Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address:

Background: Aged human skin is primarily attributable to the loss of collagen. Hepatocyte growth factor (HGF) acts as an anti-fibrotic factor by suppression of collagen production. In aged human skin, HGF is elevated in dermal fibroblasts and thus contributes to dermal aging (thin dermis) by suppression of collagen production. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Interrupting TGF-β1/CCN2/integrin-α5β1 signaling alleviates high mechanical-stress caused chondrocyte fibrosis.

Authors:
Y-Z Huang L Zhao Y Zhu S-J Tian W Zhang S Liu J-F Ge

Eur Rev Med Pharmacol Sci 2021 Feb;25(3):1233-1241

Department of Orthopedics, The Affiliated Zhangjiagang Hospital of Soochow University, Zhangjiagang, China.

Objective: Mechanical-stress has been reported to trigger cartilage fibrosis, in which transforming growth factor (TGF)-β and connective tissue growth factor (CCN2) are involved. However, the function of integrin-α5β1, a cytomembrane receptor, on mechanical-stress related fibrosis has not yet been elucidated. This study aims to reveal the interaction of TGF-β1/CCN2/integrin-α5β1 in the mechanical-stress induced chondrocyte (CH) fibrosis. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap